November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Machine Learning Blood Test Identifies Potential Early Biomarkers for Parkinson's Disease

🧠 AI Analysis 2 min read 👁 0

Researchers utilizing machine learning and plasma proteomics have identified a potential protein panel that may aid in the early detection and clinical assessment of Parkinson's disease.

🧠AI Analysis

Key points

  • Study analyzed plasma samples from 391 participants using a two-stage design.
  • Machine learning identified a five-protein panel including LAMP1, APOD, VIM, CTSF, and HEG1.
  • Selected biomarkers were also linked to cognitive scales and non-motor symptoms.

A new study published in Nature Health Sciences describes how researchers from the First Affiliated Hospital of Zhengzhou University and other institutions used machine learning and plasma proteomics to discover potential protein biomarkers for Parkinson's disease. Reliable and minimally invasive diagnostic tools for the progressive neurodegenerative condition have historically been lacking. To address this, the investigative team analyzed blood plasma samples from 391 participants using a structured, two-stage design.

During the initial discovery phase, quantitative proteomics highlighted 121 differentially expressed proteins associated with cellular processes such as oxidative stress, autophagy, and vesicle trafficking. Through a machine learning feature selection strategy, the researchers developed a specific plasma protein panel containing LAMP1, APOD, VIM, CTSF, and HEG1. Subsequent validation in an independent cohort demonstrated that this panel could effectively distinguish Parkinson's patients from healthy controls, while a simplified subset showed moderate ability to differentiate the condition from multiple system atrophy with predominant parkinsonism.

What to know: The findings suggest that specific blood proteins may eventually serve as accessible diagnostic aids, though further clinical validation in larger populations is necessary before widespread implementation. Readers should always consult a qualified healthcare provider regarding personal medical decisions and concerns.

Source Nature Health Sciences — nature.com/articles/s41531-026-01606-2 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.